Atlassian Corporation PLC (NASDAQ:TEAM – Get Free Report) CTO Rajeev Bashyam Rajan sold 3,072 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $81.35, for a total value of $249,907.20. Following the sale, the chief technology officer directly owned 212,916 shares of the company’s stock, valued at approximately $17,320,716.60. This trade represents a 1.42% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Atlassian Stock Down 5.3%
NASDAQ TEAM opened at $75.98 on Monday. The business’s 50-day moving average is $129.72 and its 200 day moving average is $150.23. The stock has a market capitalization of $20.04 billion, a PE ratio of -105.53, a PEG ratio of 63.42 and a beta of 0.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.89 and a quick ratio of 0.89. Atlassian Corporation PLC has a 1 year low of $75.01 and a 1 year high of $298.63.
Atlassian (NASDAQ:TEAM – Get Free Report) last announced its earnings results on Thursday, February 5th. The technology company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.12 by $0.10. The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.54 billion. Atlassian had a negative return on equity of 6.33% and a negative net margin of 3.29%.The firm’s revenue for the quarter was up 23.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.96 earnings per share. Sell-side analysts forecast that Atlassian Corporation PLC will post -0.34 earnings per share for the current year.
Wall Street Analyst Weigh In
Get Our Latest Analysis on Atlassian
Institutional Investors Weigh In On Atlassian
Several hedge funds have recently added to or reduced their stakes in the stock. Capco Asset Management LLC bought a new position in shares of Atlassian during the second quarter valued at $25,000. Physician Wealth Advisors Inc. grew its position in Atlassian by 60.4% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after purchasing an additional 61 shares during the last quarter. Geneos Wealth Management Inc. increased its stake in Atlassian by 447.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock valued at $42,000 after purchasing an additional 161 shares in the last quarter. Atlantic Union Bankshares Corp increased its stake in Atlassian by 19,900.0% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after purchasing an additional 199 shares in the last quarter. Finally, Board of the Pension Protection Fund purchased a new position in Atlassian in the fourth quarter worth about $32,000. 94.45% of the stock is owned by institutional investors.
Atlassian News Roundup
Here are the key news stories impacting Atlassian this week:
- Positive Sentiment: LinkedIn’s CFO is joining Atlassian — an experienced finance executive hire that can bolster leadership depth and investor confidence. LinkedIn CFO jumps to Atlassian
- Positive Sentiment: A Seeking Alpha piece upgraded TEAM to “Strong Buy,” citing accelerating revenue growth, a rising RPO/backlog, high gross margins and improved pro forma operating margins — a fundamental read that supports a recovery thesis. Atlassian: Trust Growth Acceleration And RPO Buildup (Upgrade)
- Positive Sentiment: Coverage noting Q2 performance is driving optimism about Atlassian’s growth trajectory and backlog, reinforcing the view that recent share weakness is more sentiment-driven than fundamental. Second Quarter Performance Drives Optimism Around Atlassian (TEAM)
- Neutral Sentiment: Sector context — peers like RingCentral and Five9 rallied on AI-related positive results, showing mixed sentiment in software: some firms benefit from AI tailwinds while others face selling pressure. This is a market-level factor rather than a TEAM-specific catalyst. Beaten-down software stocks RingCentral and Five9 rally as earnings quell some AI concerns
- Neutral Sentiment: Reported short-interest data in the feed is anomalous (shows 0 shares / NaN changes) and provides no actionable signal; treat as unreliable until clarified by exchanges or official reports.
- Negative Sentiment: Multiple senior executives sold shares on Feb 19 (CFO Joseph Binz, CTO Rajeev Bashyam Rajan, CRO Brian Duffy, CAO Gene Liu). While these were relatively small percentages of holdings, clustered insider selling can raise investor concern on timing and outlook. SEC filings: SEC Filing — Joseph Leo Binz Sale SEC Filing — Rajeev Bashyam Rajan Sale SEC Filing — Brian Duffy Sale SEC Filing — Gene Liu Sale
- Negative Sentiment: Pomerantz LLP launched an investor investigation into Atlassian, which introduces legal/ reputational risk and can pressure shares while the inquiry proceeds. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atlassian Corporation – TEAM
About Atlassian
Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.
Atlassian’s product portfolio centers on tools designed to help teams plan, build and support software and business processes.
Further Reading
- Five stocks we like better than Atlassian
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Atlassian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlassian and related companies with MarketBeat.com's FREE daily email newsletter.
